ReviewSemin Immunol2020
MUCIN-4 (MUC4) is a novel tumor antigen in pancreatic cancer immunotherapy.
- Journal
- Semin Immunol
- Published
- 14 January 2020
- Citations
- 49
- Type
- Review
These are bibliographic fields. A study card, with population, design, endpoints and result direction each tied to a quote, is not in the data yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess. Only its metadata is loaded so far, so most questions will be declined.
Try
Grants 4
- Project 1: The Role and Mechanism(s) of MUC16 and MUC16-Cter in Potentiating PC Metastasis P01CA217798↗
- Targeted Radiation Therapy for Pancreatic Cancer R01CA195586↗
- Validation of biomarkers for risk prediction and early diagnosis of Pancreatic Adenocarcinoma U01CA200466↗
- Pancreatic Cancer Detection Consortium U01CA210240↗